ArticlePharmaceutics2021

An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products.

Isabel Gonzalez-Alvarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.